US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 2.970
  • +0.160+5.69%
Trading Nov 25 14:28 ET
126.26MMarket Cap-1492P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Repare Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 2.341M --
-- 2024/Q4 -- / 2.733M --
-- 2024/Q3 0.000 / 2.733M --
-- 2024/Q2 1.073M / 2.929M --
-- 2024/Q1 52.404M / 38.400M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.341M--
--2024/Q4-- / 2.733M--
--2024/Q30.000 / 2.733M--
--2024/Q21.073M / 2.929M--
--2024/Q152.404M / 38.400M--

Unlock Free Earnings Estimates

Repare Therapeutics Earnings Reports

  • Repare Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 20:18

  • Repare Therapeutics | 8-K: Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results

    Nov 7 20:13

  • Repare Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 04:24

  • Repare Therapeutics | 8-K: Repare Therapeutics Provides Business and Clinical Update and Reports Second Quarter 2024 Financial Results

    Aug 7 04:15

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data